Results 211 to 220 of about 151,328 (264)

Cutaneous Administration of Nitroglycerin: A Review

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1983
Chronic administration of nitroglycerin may have important therapeutic effects in patients with angina, acute myocardial infarction, congestive heart failure and peripheral vascular disease. Because of unpredictable oral absorption and short duration of action, topical preparations provide an alternative mode of administration.
M T, Olivari, J N, Cohn
openaire   +2 more sources

Cutaneous toxicity following the administration of dactinomycin

Medical and Pediatric Oncology, 1997
Dactinomycin (AMD) is an effective drug in the management of several malignant disorders and has been used for almost 40 years. Skin and subcutaneous toxicities following extravasation are well known and can be harmful. Similarly radiation-recall is a well established phenomenon following the administration of AMD.
M J, Coppes, K, Jorgenson, J P, Arlette
openaire   +2 more sources

Cutaneous reaction associated with weekly docetaxel administration

Journal of Oncology Pharmacy Practice, 2008
Background. Docetaxel-based chemotherapy will remain clinically relevant and many of our patients will continue to receive the drug. In a recent phase 2 study of docetaxel 35 mg/m2 (weekly) in patients with metastatic breast cancer, the incidence of grade 3 cutaneous toxicity is 19%.
Chew, L., Chuen, V.S.L.
openaire   +2 more sources

Cutaneous Lesion Induced by a Subcutaneous Administration of Bortezomib

Clinical Lymphoma Myeloma and Leukemia, 2012
Introduction A 78-year-old man presented to our hospital with an indurated, painful lesion on the abdominal wall at the site of a recent subcutaneous (SC) bortezomib injection. The patient was diagnosed with multiple myeloma (MM) in 2007 after a bone marrow biopsy was done as part of anemia workup.
Karam M, Obeid, Richard, Ferrara, Mamta, Sharma   +2 more
openaire   +2 more sources

Cutaneous reactions to adalimumab administration.

Irish medical journal, 2011
Patients receiving antitumour necrosis factor-alpha treatment may develop cutaneous reactions. This human monoclonal antibody is used in the treatment of chronic inflammatory diseases, including arthritis and inflammatory bowel disease. A variety of side effects have been documented ranging from infection and vasculitis through to systemic lupus ...
M R, Downes, S, Prendiville, C, Kiely, P, Lenane, N, Mulligan   +4 more
openaire   +3 more sources

Central administration of perfluorooctanoic acid inhibits cutaneous inflammation

Inflammation Research, 2005
To elucidate the site of action of perfluorooctanoic acid (PFOA) in the carrageenan model of peripheral inflammation.Male Sprague-Dawley rats.We first compared the anti-edema effects of systemic PFOA (50-150 mg/kg) with prototypical nonsteroidal (acetylsalicylic acid, ASA, 50-200 mg/kg) and steroidal (dexamethasone, 0.5-5.0 mg/kg) drugs after the ...
B K, Taylor, C, Kriedt, S, Nagalingam, N, Dadia, M, Badr   +4 more
openaire   +2 more sources

Cutaneous Atrophy Secondary to Intra-articular Corticosteroid Administration

Annals of Internal Medicine, 1966
Excerpt Intra-articular injection of adrenocorticosteroid has been shown to be a useful therapeutic procedure in the management of patients with rheumatoid arthritis.
J T, Cassidy, G G, Bole
openaire   +2 more sources

Hepatotoxicity and cutaneous reactions after antithyroid drug administration

Clinical Endocrinology, 2012
SummaryObjectiveUse of the antithyroid drugs (ATDs) thiamazole (MMI) and propylthiouracil (PTU) is associated with a high frequency of side effects. When patients experience side effects with one (the 1st) ATD, it is usually discontinued and another is administered (the 2nd ATD).
Fumiko, Otsuka, Jaeduk Y, Noh, Toshiko, Chino, Taeko, Shimizu, Koji, Mukasa, Kunihiko, Ito, Koichi, Ito, Matsuo, Taniyama   +7 more
openaire   +2 more sources